Read + Share
Amedeo Smart
Independent Medical Education
Henry C. Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. N Engl J Med 2025;392:1556.PMID: 40239081
Email
LinkedIn
Privacy Policy